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ABSTRACT
Prenatal maternal stress exposure has been associated with neonatal differential DNA methylation.
However, the available evidence in humans is largely based on candidate gene methylation studies,
where only a few CpG sites were evaluated. The aim of this study was to examine the association
between prenatal exposure to maternal stress and offspring genome-wide cord blood methylation
using different methods. First, we conducted a meta-analysis and follow-up pathway analyses.
Second, we used novel region discovery methods [i.e., differentially methylated regions (DMRs)
analyses]. To this end, we used data from two independent population-based studies, the
Generation R Study (n D 912) and the Avon Longitudinal Study of Parents and Children (ALSPAC,
n D 828), to (i) measure genome-wide DNA methylation in cord blood and (ii) extract a prenatal
maternal stress composite. The meta-analysis (ntotal D 1,740) revealed no epigenome-wide (meta
P <1.00e-07) associations of prenatal maternal stress exposure with neonatal differential DNA
methylation. Follow-up analyses of the top hits derived from our epigenome-wide meta-analysis
(meta P <1.00e-04) indicated an over-representation of the methyltransferase activity pathway. We
identiﬁed no Bonferroni-corrected (P <1.00e-06) DMRs associated with prenatal maternal stress
exposure. Combining data from two independent population-based samples in an epigenome-wide
meta-analysis, the current study indicates that there are no large effects of prenatal maternal stress
exposure on neonatal DNA methylation. Such replication efforts are essential in the search for
robust associations, whether derived from candidate gene methylation or epigenome-wide studies.
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Introduction
Exposure to maternal stress in utero can negatively affect devel-
opment in later life.1-4 For example, prenatal exposure to
maternal depressive symptoms5 and contextual stress (e.g., eco-
nomic disadvantage)6 have been associated with increased risk
for offspring problem behavior, beyond variance attributable to
postnatal exposures. It is increasingly recognized that epige-
netic mechanisms, such as DNA methylation, might help
explain the link between prenatal exposure to maternal stress
and adverse developmental consequences.7,8 The extent to
which prenatal maternal stress exposure relates to offspring
genome-wide DNA methylation at birth remains unclear.
The vast majority of studies investigating the association
between prenatal exposure to maternal stress and offspring
methylation at birth have focused on candidate genes.9-14 For
example, Cecil et al.9 demonstrated that neonates who were
exposed to maternal stress (e.g., maternal psychopathology, crim-
inal behaviors, substance use) in the prenatal period had higher
methylation levels of the oxytocin receptor (OXTR) gene than
non-exposed neonates. Higher neonatal OXTR methylation, in
turn, showed temporal stability (from birth to 9 y of age) and
was associated with callous-unemotional traits at age 13 y, inde-
pendently of postnatal stress exposure and associated OXTR
methylation.9 Similarly, prenatal exposure to maternal depressive
symptoms has been associated with altered methylation of the
serotonergic SLC6A4 gene,10 the glucocorticoid receptor
(NR3C1) gene,11 and imprinted genes12-14 in neonates or infants.
Overall, the ﬁndings of these candidate gene studies support the
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“fetal programming hypothesis,”15 suggesting that exposure of
the fetus to maternal stress in uteromay inﬂuence DNAmethyla-
tion in genes involved in fundamental developmental processes.
Since strong prior biological knowledge of the complex asso-
ciation between prenatal maternal stress exposure and offspring
differential DNA methylation is lacking, it is critical to perform
hypothesis-free, epigenome-wide association studies (EWASs)
in addition to candidate gene studies.16,17 The few EWASs that
have investigated the association between prenatal maternal
stress exposure and offspring DNA methylation suffer from
small sample sizes with limited generalizability and they have
produced conﬂicting ﬁndings.18 Non et al.19 reported an associ-
ation between prenatal exposure to maternal depression and
offspring DNA methylation in 36 mother-offspring pairs. How-
ever, using a larger but still modest sample of 201 neonates
born to mothers receiving psychiatric care, Schroeder et al.20
reported that maternal depression during pregnancy was unre-
lated to neonatal DNA methylation. Another small EWAS
(n D 36) provided evidence that prenatal exposure to a natural
disaster (i.e., the Quebec ice storm in 1998) was associated with
offspring methylation in multiple genes predominantly related
to immune function.21 However, DNA methylation was mea-
sured eight to 13 y after exposure and it cannot be excluded
that the observed DNA methylation patterns were associated
with unmeasured long-lasting environmental factors that
were related to the original natural disaster but occurred after
the prenatal period. As such, EWASs must be conducted in
large samples of neonates and their mothers before more deﬁ-
nite conclusions can be reached.
The aim of this study was to examine the association between
prenatal exposure to maternal stress and offspring genome-wide
cord blood methylation using different methods. First, we con-
ducted a meta-analysis and follow-up pathway analyses. Second,
we used novel region discovery methods [i.e., differentially
methylated regions (DMRs) analyses] that are tailored to the
Illumina Inﬁnium HumanMethylation450 BeadChip array22
but are not designed for meta-analysis. To this end, we used data
from two independent population-based studies, the Generation
R Study (n D 912) and the Avon Longitudinal Study of Parents
and Children (ALSPAC, n D 828), to (i) measure genome-wide
DNA methylation at birth (via cord blood), when it is not con-
founded by the effects of stressful postnatal conditions, and (ii)
extract a prenatal maternal stress composite. The fact that
ALSPAC and Generation R are highly compatible enabled us to
study 450K HumanMethylation neonatal methylation in similar
populations and use a similar phenotype deﬁnition. Of note,
although the 450K HumanMethylation array is considered a
highly suitable platform for large-scale studies, it targets only
<2% of the CpG sites present in the human genome.17 The cur-
rent study is one of the largest in this emerging ﬁeld of EWAS,
and the built-in meta-analysis and follow-up analyses might
serve as a model for future studies.
Methods
Study design and participants
This study used data from two population-based cohorts,
the Generation R Study and the Avon Longitudinal Study
of Parents and Children (ALSPAC). Generation R is an
ongoing epidemiological study of children born from 9,778
pregnant women residing in Rotterdam, the Netherlands,
with expected delivery dates between April 2002 and Janu-
ary 2006. The design and sample characteristics of the
Generation R Study have been described in detail else-
where.23,24 The study was conducted in accordance with
the guidelines proposed in the World Medical Association
Declaration of Helsinki and was approved by the Medical
Ethical Committee of the Erasmus University Medical
Center, Rotterdam. The current research used a subsample
of 969 Caucasian Dutch neonates and their mothers drawn
from the Generation R Focus Study, an ethnically homoge-
neous subsample nested within the Generation R cohort,
who had epigenetic data at birth that successfully passed
quality control.
ALSPAC is an ongoing epidemiological study of children
born from 14,541 pregnant women residing in Avon, UK, with
an expected delivery date between April 1991 and December
1992 (85% of eligible population).25 The sample is representa-
tive of the general population.26 More details of the available
data are available in the study website through a fully search-
able data dictionary (http://www.bris.ac.uk/alspac/researchers/
data-access/data-dictionary/). Ethical approval was obtained
from the ALSPAC Law and Ethics Committee as well as Local
Research Committees. The current research used a subsample
of 914 mother-offspring pairs drawn from the Accessible
Resource for Integrated Epigenomics Studies (ARIES,27 www.
ariesepigenomics.org.uk) nested within ALSPAC, who had
cord blood methylation data available that successfully passed
initial quality control, before carrying out additional quality
steps (see below).
Except for the factor analysis on prenatal adversities, in
which we used data from all participants, the present study
only included participants who had complete data for prenatal
maternal stress exposure and methylation data (Generation R:
n D 912; ALSPAC: n D 828). In both studies parents signed
written consent for participation.
Measures
DNA methylation data
In Generation R and ALSPAC, 500 nanograms of DNA
from cord-blood (birth, nGeneration R D 979; nALSPAC D 914)
underwent bisulﬁte conversion using the EZ-96 DNA Meth-
ylation Kit (Zymo Research Corporation, Irvine, USA). The
Illumina Inﬁnium HumanMethylation450 BeadChip Kit
(Illumina Inc., San Diego, USA) was used to measure DNA
methylation at 485,577 CpG probes. In both datasets, initial
quality control of data generated was conducted to deter-
mine the status of staining, extension, hybridization, target
removal, bisulﬁte conversion, speciﬁcity, non-polymorphic
and negative controls.
The Generation R sample included the 969 neonates who
had DNA methylation data that passed quality control. All
49,564 probes identiﬁed as having (i) a single nucleotide poly-
morphism in the single base extension site with a frequency of
> 1% in the GoNLv4 reference panel28 or (ii) a non-optimal
binding (non-mapping or mapping multiple times to either the
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normal or the bisulﬁte-converted genome) were removed from
the data set, leaving a total of 436,013 CpG probes for analysis.
In ALSPAC, DNA methylation data was only available in
samples that passed initial control. Furthermore, samples
(n D 25) or probes (n D 7,873) that failed additional qual-
ity control steps (>1 % probes/ samples with background
detection P-value >D 0.05) were excluded from further
analyses. In ALSPAC, participants with non-Caucasian or
missing ethnicity (based on self-reports, n D 61) were
removed prior to the analysis. This left a total of 828 sam-
ples and 477,704 probes after quality control.
Both samples were normalized using the dasen method
described by Pidsley et al.29 and dye bias corrected.30 Nor-
malized values are b-values, which represent the methyla-
tion level at a CpG probe for each neonate. Last, only
probes (n D 429,074) that were present in both Generation
R and ALSPAC datasets (i.e., probes that passed quality
control in both data sets) were included in all analyses.
Prenatal maternal stress exposure
A prenatal maternal stress exposure (PMSE) score had been
previously created in ALSPAC based on maternal reports, cov-
ering four stress domains: (i) life stress (e.g., death in family, ill-
ness, work problems), (ii) contextual stress (e.g., ﬁnancial
difﬁculties, housing problems), (iii) personal stress (e.g., psy-
chopathology, substance abuse including alcohol and drugs),
and (iv) interpersonal stress (e.g.,, family relationship difﬁcul-
ties, arguments with partner).9 ALSPAC and Generation R
have highly compatible measures enabling us to create a similar
PMSE score in Generation R, based on maternal reports. For
each domain, items were summed and divided by the number
of completed items. Inter-correlations between the risk domain
scores were positive (all P < 0.001). Conﬁrmatory factor analy-
sis (CFA) in Mplus 7.1131 was used to assess the internal reli-
ability of the stress domains and to extract one PMSE score in
the whole Generation R cohort, showing good model ﬁt
(RMSEA; acceptable ﬁt  0.08; CFI and TLI; acceptable ﬁt 
0.90).32,33 See Supplementary Material for full item descriptions
(Table S1), inter-correlations between the stress domains
(Table S2), and the conﬁrmatory factor analysis model and ﬁt
indices (Fig. S1).
In both studies, the PMSE score was logarithmic (base
10) transformed to approximate a normal distribution.
Additionally, the transformed PMSE score was translated
into z scores and screened for outliers (values were Winsor-
ized when z-score  3.29, affecting n D 8 measurements in
Generation R and n D 5 in ALSPAC). These analyses were
conducted in SPSS 21.0 statistical package.34
Covariates
We adjusted for technical covariates, including the sample’s
array number and position on the array. Following the methods
developed by Houseman et al,35 we included estimated propor-
tions of cells in whole blood [proportion of CD8C T-cells,
CD4C T-cells, natural killer (NK) cells, B-cells, monocytes and
granulocytes] to adjust for different cell type compositions.
Because the cell type proportions add up to approximately
100%, granulocytes were excluded to avoid multicollinearity.
Furthermore, we included as covariates child sex, gestational
age at birth, and maternal smoking during pregnancy. In Gen-
eration R, information on child sex was obtained from midwife
and hospital registries at birth. Gestational age at birth was
established by fetal ultrasound examination. Information on
maternal tobacco smoking was obtained by postal question-
naires in early, mid, and late pregnancy. Maternal smoking was
categorized on the basis of all three questionnaires into “never
smoked during pregnancy,” “quit as soon as pregnancy was
known,” and “continued smoking during pregnancy.” In
ALSPAC, information on child sex and gestational age at birth
was obtained from self-reports, health and administrative
records. Information on maternal tobacco smoking was
obtained by self-reported questionnaires in early, mid, and late
pregnancy.
Statistical analysis
Epigenome-wide association study (EWAS)
and meta-analysis
First, single probe analyses investigating the association
between the PMSE score and neonatal DNA methylation were
performed for the CpG probes (n D 429,074) that passed qual-
ity control in both the Generation R and ALSPAC cohorts. We
used a linear mixed effects model, adjusting for ﬁxed (i.e., gesta-
tional age, sex, maternal smoking during pregnancy, cell types
estimation) and random (i.e., the sample’s array number and
position on the array) covariates.
Second, to maximize power to detect an association of
the PMSE score with DNA methylation in neonates, we
combined the data from the two independent samples in an
EWAS meta-analysis. In this study, we performed both
ﬁxed- and random-effects, inverse-variance meta-analysis
using the methods implemented in METAL (Meta-Analysis
Helper),36 and METASOFT,37 respectively. We also investi-
gated evidence of heterogeneity in the Generation R and
ALSPAC data using the I2- statistic,38 considering only
results with no strong evidence of heterogeneity (Heteroge-
neity P > 0.05) for further analysis. Of note, the power to
detect heterogeneity is limited with small numbers of stud-
ies. Bonferroni (P D 1.00e-07) and FDR corrections were
applied as epigenome-wide thresholds.
We conducted a sensitivity EWAS of extreme groups in
Generation R to test the possibility that only extreme prenatal
maternal stress would lead to differential methylation. Speciﬁ-
cally, we dichotomized PMSE according to the 10% highest
(n D 91) and the 10% lowest (n D 82) scores and used this
binary variable in a discovery EWAS.
Correlation test
A correlation test was used to investigate the linear relationship
of the effect sizes of CpG probes between the Generation R and
ALSPAC samples. To this end, all CpG probes showing an
association at a nominal threshold level (meta P < 0.05) in our
EWAS meta-analysis were selected and the Pearson correlation
of the effect sizes between the Generation R and ALSPAC sam-
ples was estimated. We also considered the sign of the regres-
sion coefﬁcients.
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Epigenome-wide pathway analyses
To investigate whether speciﬁc pathways are over-represented
in our EWAS meta-analysis results, epigenome-wide pathway
analyses were performed. For this purpose, all top hits derived
from the EWAS meta-analysis (meta P < 1.00e-04) were
selected and annotated to genes, using the IlluminaHumanMe-
thylation450kCHR36 ﬁle. We used 3 different tools to sort
these genes into pathways: (i) the PANTHER 9.0 pathway-clas-
siﬁcation tool,39 using the Gene Ontology (GO)-Slim Molecular
Function annotation dataset,40 (ii) DAVID (Database for
Annotation, Visualization, and Integrated Discovery),41 and
(iii) GeneMANIA,42 based on GO terms. These methods adjust
for differential gene size but not the unusual distribution of
450K HumanMethylation probes with respect to the gene. It is
recommended to use multiple tools when conducting pathway
analysis, to overcome methodological challenges speciﬁc to
each tool.43
Differentially methylated regions (DMRs) analysis
Differentially Methylated Regions (DMRs) are deﬁned as at
least two spatially contiguous probes within 1 kb distance of
each other and with a differential statistic consistently less than
the 5th (for negative associations) or more than the 95th per-
centile (for positive associations).44 To identify DMRs associ-
ated with PMSE in neonates, we ﬁrst used the clusterMaker
function of the bumphunter package45 to assign CpG probes
into clusters, separated with a maximum distance of 1kb within
the Generation R sample. For each cluster, we used the Glob-
alTest statistical package46 to test the association between pre-
natal stress and differential methylation of each of these
clusters, using a linear regression model, while adjusting for
covariates. Finally, the top clusters identiﬁed in the Generation
R sample were tested for association with PMSE in the
ALSPAC sample, using the same linear regression model in the
GlobalTest statistical package.
Results
Sample characteristics
The sample characteristics for all mothers and children partici-
pating in this study are presented in Table 1. The distribution
of mean cord blood methylation values (b-values) in Genera-
tion R (n D 912) and ALSPAC (n D 828) is presented in
Table 2.
Epigenome-wide association analysis meta-analysis
Both the individual study epigenome-wide analyses and themeta-
analysis (ntotalD 1,740) revealed no epigenome-wide (Bonferroni-
or FDR-corrected P-value) association of the PMSE score with
neonatal DNAmethylation. The top 10 CpG probes derived from
the ﬁxed-effects EWAS meta-analysis are presented in Table 3.
More detailed tables with all top CpG probes (P < 1.00e-04)
derived from the EWAS in the Generation R and ALSPAC sam-
ples, as well as the EWAS meta-analysis in the total sample, can
be found in the Supplementary Material (Tables S3-S5, respec-
tively). The Manhattan and quantile-quantile plot of the EWAS
meta-analysis are presented in Figs. 1, 2, respectively. The ran-
dom-effects EWAS meta-analysis revealed similar results as the
ﬁxed-effects EWAS meta-analysis. All top CpG probes identiﬁed
by the random-effects EWAS meta-analysis are presented in the
Supplementary Material (Table S6). Finally, the nCpGs D 39,308
probes with weak evidence of differential methylation in the
EWASmeta-analysis (meta P< 0.05) showed a strong correlation
across the two samples [r(39,308) D 0.75, P < 0.01]. Of these
39,308 CpG correlations, 38,000 (97%) went in the same direction
across Generation R and ALSPAC.
The sensitivity EWAS of extreme groups (i.e., 10% highest
vs. 10% lowest PMSE scores) in Generation R similarly revealed
no epigenome-wide association of PMSE with neonatal DNA
methylation (data available upon request).
Epigenome-wide pathway analysis
Three different pathway analyses tools (i.e., PANTHER,
DAVID, and GeneMANIA) were used to test for over-repre-
sentation of speciﬁc pathways within the top CpG probes
(meta P < 1.00e-04) identiﬁed by our EWAS meta-analysis.
The methyltransferase activity pathway was enriched in both
PANTHER (Bonferroni-corrected P D 0.002) and GeneMA-
NIA (false discovery rate, FDR P D 4.76e-04), and marginally
enriched in DAVID (FDR P D 0.06) after correction for the
number of pathways tested. Note that the same genes can par-
ticipate in different pathways, making them not completely
independent. The output of the pathway analysis tools is pre-
sented in Table 4.
Differentially methylated regions (DMRs) analysis
In Generation R, ntotal D 151,704 clusters were identiﬁed, of
which n>2 D 49,091 clusters contained more than 2 probes.
Table 1. Sample characteristics.
Generation R (n D 912) ALSPAC (n D 828)
Child characteristics
Sex, % girls 48.4 48.9
Gestational age, weeks 40.2 (1.43) 39.6 (1.50)
Maternal characteristics
Age, years 31.7 (4.13) 29.56 (4.39)
PMSE score, log transformed 0.15 (0.11) 0.25 (0.14)
Smoking during pregnancy, %
never 77.5 87.1
until pregnancy was conﬁrmed 7.7 3.4
continued 14.8 9.5
 Values represent mean (standard deviation), unless otherwise speciﬁed.
Table 2. Summary of the number of CpGs and their proportional distribution
according to mean methylation (b-value) density in the Generation R and ALSPAC
samples.
Mean b-value in cord blood
Generation R <0.3  0.3 to 0.7  0.7 Total
CpGs (n) 181,765 51,296 202,952 436,013
CpGs as proportion
of total array (%)
42 11 47 100
ALSPAC
CpGs (n) 187,967 69,082 220,655 477,704
CpGs as proportion
of total array (%)
39 15 46 100
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These 49,091 clusters were tested for an association with the
PMSE score. This analysis identiﬁed no Bonferroni-corrected
(P D 0.05/49,091 D 1.00e-06) DMRS associated with prenatal
maternal stress exposure in the Generation R sample. However,
three DMRs, located in 20q13.33, 7q33, and 17q25.1, showed
marginal associations with prenatal maternal stress. These three
top DMRs were taken forward for replication in the ALSPAC
sample. None of these regions were associated with PMSE in
the ALSPAC sample. The results of the DMR analysis are pre-
sented in Table 5. A detailed annotation table of the DMRs can
be found in the Supplementary Material (Table S7).
Discussion
This study followed a hypothesis-free epigenome-wide (EWAS)
approach to identify novel differentially methylated sites in the
cord blood of neonates exposed to prenatal maternal stress.
Both the study-speciﬁc epigenome-wide analyses in two
independent population-based cohort studies, Generation R
(n D 912) and ALSPAC (n D 828), and the EWAS meta-analy-
sis in the total sample (ntotalD 1,740), failed to provide evidence
of Bonferroni-corrected DNA methylation differences in the
cord blood of children exposed to prenatal maternal stress. The
correlation test of the CpG probes (nCpGs D 39,308) showing
an association at a nominal threshold level in our EWAS meta-
analysis (meta P < 0.05), indicated convergence between the
Generation R and ALSPAC samples [r(39,308) D 0.75,
P < 0.01].
Even though the current EWAS has signiﬁcantly more sta-
tistical power to detect effects than the previous EWAS by
Schroeder et al,20 who reported no differential DNA methyla-
tion in 201 neonates born to mothers with a lifetime history of
mood disorder, it still ﬁnds only weak evidence. Cao-Lei et al.21
reported that prenatal exposure to a natural disaster was associ-
ated with offspring differential methylation (n D 36) in several
genes during childhood. Furthermore, Non et al.19 showed that
DNA methylation differed between neonates exposed to non-
medicated maternal depression or anxiety (n D 13) vs.
Table 3. Top 10 CpG probes (meta P < 1.00e-04) derived from the EWAS meta-analysis of prenatal maternal stress exposure in neonates, sorted by ascending meta
P-value (ntotalD 1,740).
Generation R (n D 912) ALSPAC (n D 828) Meta-analysis (ntotal D 1,740)
Probe name Chromosome Position Effect (SE) P Effect (SE) P Effect (SE) Direction Meta P Het P Nearest gene (s)
cg13529437 6 43607635 ¡0.04 (0.009) 3.31e-06 ¡0.03 (0.016) 1.15e-01 ¡0.04 (0.007) — 1.00e-06 .47 MAD2L1BP
cg04129946 2 201753996 0.02 (0.006) 2.63e-04 0.02 (0.007) 9.71e-03 0.02 (0.004) CC 7.59e-06 .73 PPIL3;NIF3L1
cg20959676 1 23696021 0.01 (0.003) 6.54e-03 0.02 (0.005) 1.01e-04 0.01 (0.003) CC 8.67e-06 .09 C1orf213;ZNF436
cg17631424 4 69312514 ¡0.06 (0.016) 2.64e-04 ¡0.05 (0.022) 1.53e-02 ¡0.06 (0.013) — 1.13e-05 .81 TMPRSS11E
cg19459675 4 166249239 0.02 (0.005) 7.99e-04 0.02 (0.006) 6.72e-03 0.02 (0.004) CC 1.59e-05 .76 SC4MOL
cg12947485 4 25310668 ¡0.04 (0.010) 6.78e-04 ¡0.04 (0.015) 5.84e-03 ¡0.04 (0.009) — 1.71e-05 .75 NA
cg20011562 6 12749352 0.01 (0.003) 2.78e-02 0.01 (0.004) 9.98e-05 0.01 (0.002) CC 1.85e-05 .18 PHACTR1
cg02644494 19 6412686 0.02 (0.008) 2.30e-03 0.03 (0.009) 2.77e-03 0.03 (0.006) CC 1.88e-05 .82 PVRL1
cg01686933 11 119596104 ¡0.02 (0.008) 6.49e-03 ¡0.03 (0.008) 1.11e-03 ¡0.02 (0.006) — 2.12e-05 .81 NA
cg00409356 5 1879525 0.05 (0.012) 5.86e-05 0.02 (0.013) 5.75e-02 0.04 (0.009) CC 2.17e-05 .17 IRX4
input order: the Avon Longitudinal Study of Parents and Children (ALSPAC) Study, the Generation R Study.
The prenatal maternal stress exposure score was not standardized and ﬁndings cannot be directly compared across ALSPAC and the Generation R Study.
NA: not available.
Figure 1. Manhattan plot of the EWAS meta-analysis of the PMSE score in cord blood (ntotal D 1,740). The x-axis represents the autosomal (1–22) and sex (X,Y) chromo-
somes and the y-axis shows the –log10(P). The red line indicates the Bonferroni-corrected epigenome-wide threshold (P D 1.00e-07).
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unexposed neonates (n D 23). It is noteworthy that these stud-
ies differ in the operationalization (i.e., psychopathology vs.
natural disaster) and the timing (i.e., life-time vs. acute) of
stress exposure. According to a recent meta-analysis, the effect
of prenatal maternal stress exposure on infant birth weight and
gestational age may vary according to how stress is operational-
ized.47 In the current study, we used a prenatal maternal stress
exposure construct that incorporated a variety of stress
domains. It is possible that the effects of prenatal maternal
stress exposure are more subtle than those of acute extremely
stressful events (e.g., a natural disaster) and that larger sample
sizes are needed to identify these small, but potentially biologi-
cally important DNA methylation differences in cord blood.
Another possibility is that there is no genome-wide DNA meth-
ylation effect in neonates in the general population. Of note,
our sensitivity analysis of extreme groups (10% highest vs. 10%
lowest prenatal maternal stress) similarly revealed no Bonfer-
roni-corrected hits, which further supports the results of our
meta-analysis but was very underpowered to conﬁrm if there is
a threshold effect of prenatal stress exposure on neonatal DNA
methylation.
Of the CpG probes that did not surpass epigenome-wide
thresholds in our study, the top hit (cg13529437, meta
P D 1.00e-06) was located in chromosome 6p21.1, in the
MAD2L1BP gene. The product of this gene participates in
the mitotic checkpoint complex, acting as a regulator of the
cell cycle.48 In cell lines, the MAD2L1BP gene was found to
be induced by stressful events, such as ionizing radiation.49
However, in light of the observed sub threshold effects, we
would like to point out that the exact contribution of this
gene in conditions of maternal stress exposure is not
straightforward and warrants further investigation.
Exploratory follow-up analysis of the top CpG probes (meta
P < 1.00e-04) identiﬁed by our EWAS meta-analysis indicated
an over-representation of the methyltransferase activity path-
way. Methyltransferases are a large group of enzymes with the
ability to methylate their substrates.50 Among our top EWAS
meta-analytic results, both DNA and protein-methyltransfer-
ases were found. These results support previous research indi-
cating that the methyltransferases regulating gene expression
through DNA or histone methylation may also be under epige-
netic control.51,52 This ﬁne-tuned regulation of the epigenetic
machinery offers an attractive system for feedback regulation
and/or escalation of the response to initial environmental stim-
uli. For example, it has been suggested that epigenetic gene reg-
ulation associated with the altered expression of DNA
methyltransferases is responsive to prenatal stress exposure53,54
and involved in the pathophysiology of schizophrenia55,56 and
Figure 2. Quantile-quantile (QQ) plot illustrating probability values from the EWAS meta-analysis of the PMSE score in cord blood (ntotal D 1,740). The red line indicates
the distribution under the null hypothesis and the shaded area indicates the 95% conﬁdence band.
Table 4. Pathway analysis of top CpG probes (meta P < 1.00e-04) derived from the EWAS meta-analysis of prenatal maternal stress exposure in neonates (ntotal D 1,740).
Pathway tool Output
PANTHER GO-slim Molecular Function Expected ngenes Observed ngenes Fold enrichment Pathway enrichment P
Methyltransferase activity 0.26 4 >5 0.002$
DAVID Count Coverage Enrichment score Pathway enrichment P
Methyltransferase activity 5 1.1% 2.46 0.06
GeneMANIA Coverage Pathway enrichment P
Methyltransferase activity 7/87 4.76e-04
$PANTHER reports the Bonferroni methodDAVID and GeneMANIA report the Benjamini-Hochberg (false-discovery rate, FDR) method.
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mood disorders.57 Future molecular and animal studies are
needed to test this hypothesized mechanism.
The differentially methylated regions (DMRs) analysis in the
Generation R sample identiﬁed three clusters in 20q13.33,
7q33, and 17q25.1 showing marginal associations with prenatal
maternal stress. However, we were unable to replicate these
clusters in the ALSPAC sample. These results highlight a major
challenge of epigenetic epidemiology, which is to disentangle
which associations are sample-speciﬁc, stochastic, or replicable,
and eventually generalizable.17
We argue that the stress domains used in the current
study, more so than acute disaster-type stresses studied by
Cao-Lei et al.,21 are potentially generalizable to the broader
population. Natural disasters are less common than ﬁnan-
cial and relationship difﬁculties, at least in Western indus-
trialized countries. These ﬁnancial and relationship
difﬁculties are potentially more amenable to interventions
than natural disasters. Hence, understanding the molecular
consequences could inform prioritization of interventions in
public health strategy. Using a more normative range of
prenatal stresses, the current study promises to have wide-
spread implications. Because the magnitude of these associ-
ations in terms of cell biology is unclear, the nominally
signiﬁcant results could include biologically important asso-
ciations even if the change in methylation is quite subtle.
Additionally, it is possible that the different stress domains
exert differential effects on neonatal DNA methylation, and
should be tested independently. However, in our samples
the separate stressors showed skewed distributions that
might lead to false positive ﬁndings. The aggregate score of
these stressors better approximated a normal distribution,
and therefore was used in our statistical analyses to capture
the stressful environment to which both the mother and the
fetus had been exposed.
Another potential factor to be taken into account in future
EWASs is the timing of the prenatal maternal stress exposure.
In support of the fetal programming hypothesis, Tobi et al.58
showed in a recent EWAS that prenatal famine exposure in
early gestation, but not in mid- or late gestation, is associated
with DNA methylation. Findings of a recent EWAS by Rich-
mond et al.59 suggest that, in contrast to the view that early
pregnancy represents a critical time-window for inﬂuencing
development, sustained exposure of the fetus to maternal
smoking in utero is required to induce neonatal DNA methyla-
tion modiﬁcations. The prenatal maternal stress measures used
in the current study spanned 12 to 30 weeks of pregnancy and
most indicators were assessed only once during pregnancy.
There is a need for longitudinal EWASs investigating the rela-
tive roles of the early, mid, and late intrauterine environment
in stress-induced DNA methylation changes, in order to iden-
tify the targets and timing of intervention.
The present results should be interpreted in the context of
three main limitations. First, our analyses are limited to cord
blood samples with heterogeneous cell types. Although it has
become common practice to adjust for the proportion of cell
types in the blood in EWASs,35 this approach has been vali-
dated for adults and not for cord blood samples. Alternative
methods are needed to assess cell mixture distribution in cord
blood. Second, although it has been shown that blood samples
are adequate proxies of DNA methylation in other tissues (e.g.,
the brain60), there is also accumulative evidence of tissue-spe-
ciﬁc DNA methylation.61 Future research could investigate the
effects of prenatal maternal stress exposure in speciﬁc tissues
and cell types. Finally, an inherent characteristic of EWAS is
that methylation at the majority of the CpG probes measured
by the Illumina 450K array are either fully methylated or
unmethylated, showing low variation between individuals.62
These CpG probes may be irrelevant for gene-expression regu-
lation, and it is as yet unclear how this (lack of) variation
should be taken into account. The Bonferroni correction for
multiple testing as applied in this study could be in fact too
strict, and alternative methods [e.g., selection of intermediate
(mean b  0.3–0.7) or variable (SD  0.05) methylated CpG
probes,62 use of region discovery methods,44 or estimation of
equivalent number of independent variables63], are currently
under development and can increase the power to detect true
associations.
The present population-based study is the ﬁrst, to our
knowledge, to examine the association between prenatal mater-
nal stress exposure and offspring genome-wide cord blood
methylation using meta-analysis and novel region discovery
methods. Meta-analysis approaches are widely used in
genome-wide association studies and have identiﬁed many
genetic variants, which could not be revealed in the individual
studies.64 This study may showcase that a straight-forward
approach in EWAS can be unsuccessful in terms of ﬁnding sig-
niﬁcant associations for speciﬁc probes, and that more sophisti-
cated ways should be employed in epigenetic studies, whenever
possible. The technical/ methodological properties of methyla-
tion arrays (e.g., limited coverage of the genome, cross-hybrid-
ization65,66), combined with the fact that inherently small effect
sizes have been observed in small samples without replication
in independent samples or model systems (e.g., cell lines and
animal models), raise concerns regarding the replicability of
the ﬁndings presented in the literature.17
Combining data from two independent population-based
samples of mothers and neonates in an EWAS meta-analysis,
this study identiﬁed no single CpG probe with strong associa-
tions with prenatal maternal stress exposure. The search for dif-
ferentially methylated regions across the genome was followed
up with several complementary approaches, including a corre-
lation test, DMRs, and pathway analyses. The extent to which
Table 5. Top Differential Methylated Regions (DMRs) associated with prenatal maternal stress exposure in the Generation R (n D912) and ALSPAC (n D 828) samples.
Cluster Number n CpGs Chromosome Start Position End Position PGeneration R PALSPAC Nearest gene(s)
90946 3 20 62948037 62948235 3.75e-06 0.72 MYT1;LINC00266-1;CICP4
135488 11 7 133811808 133812369 1.27e-05 0.52 LRGUK
66361 15 17 73974861 73976089 3.55e-04 0.63 ACOX1; C17orf106
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the severity, duration, and timing of prenatal stress exposures
associate with neonatal DNA methylation should be further
investigated in large longitudinal studies with more extreme
variations in relevant phenotypes.
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